Connection

Andrew Jakymiw to Cell Line, Tumor

This is a "connection" page, showing publications Andrew Jakymiw has written about Cell Line, Tumor.
Connection Strength

0.332
  1. Fusogenic-oligoarginine peptide-mediated silencing of the CIP2A oncogene suppresses oral cancer tumor growth in vivo. J Control Release. 2015 Nov 28; 218:72-81.
    View in: PubMed
    Score: 0.088
  2. Identification and characterization of Dicer1e, a Dicer1 protein variant, in oral cancer cells. Mol Cancer. 2014 Aug 13; 13:190.
    View in: PubMed
    Score: 0.081
  3. Fusogenic-oligoarginine peptide-mediated delivery of siRNAs targeting the CIP2A oncogene into oral cancer cells. PLoS One. 2013; 8(9):e73348.
    View in: PubMed
    Score: 0.076
  4. Overexpression of dicer as a result of reduced let-7 MicroRNA levels contributes to increased cell proliferation of oral cancer cells. Genes Chromosomes Cancer. 2010 Jun; 49(6):549-59.
    View in: PubMed
    Score: 0.061
  5. CIP2A expression and localization in oral carcinoma and dysplasia. Cancer Biol Ther. 2010 Oct 01; 10(7):694-9.
    View in: PubMed
    Score: 0.016
  6. The RNA binding protein Sam68 is acetylated in tumor cell lines, and its acetylation correlates with enhanced RNA binding activity. Oncogene. 2004 May 06; 23(21):3781-9.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.